Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries | Eli Lilly and Company
The Pharma Data
MAY 4, 2021
. “ Lilly ‘s action provides both important new options and potential resources for countries’ health and regulatory leaders to consider for the care of COVID-19 patients, and Direct Relief will of course move with urgency upon receiving any such requests.” It is approved in the U.S.
Let's personalize your content